Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor
- Publication date
- 1 January 2011
- Publisher
- Health Sciences Research Commons